The complete remission concept

Drugs of Today

Volumn 42, Issue SUPPL. B, 2006, Pages 9-14

  Mönnikes, Hubert ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE; PANTOPRAZOLE;

CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HUMAN; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; REMISSION; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ANTI-ULCER AGENTS; ESOPHAGOSCOPY; GASTROESOPHAGEAL REFLUX; GASTROSCOPY; HUMANS; OMEPRAZOLE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; STATISTICS;

EID: 33947263832     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (16)

1. Galmiche, J.P., Bruley des Varannes, S. Symptoms and disease severity in gastroesophageal reflux disease. Scand J Gastroenterol 1994, 201 (Suppl): 62-68.
2. Stanghellini, V. ReQuest™: New dimensions in the assessment and management of GERD. Drugs Today 2005, 41 (Suppl B): 7-11.
3. Armstrong, D. Endoscopic evaluation of gastro-esophageal reflux disease. Yale J Biol Med 1999, 72: 93-100.
4. Stanghellini, V., Armstrong, D., Mönnikes, H., Bardhan, K.D. Systematic review: Do we need a new gastro-esophageal reflux disease questionnaire? Aliment Pharmacol Ther 2004, 19(5): 463-79.
5. Carlsson, R., Dent, J., Boling-Sternevald, E. et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroentrol 1998, 33(10): 1023-9.
6. Armstrong, D., Mönnikes, H., Bardhan, K.D., Stanghellini, V. The construction of a new evaluative GERD questionnaire - methods and state of the art. Digestion 2004, 70(2): 71-8.
7. Bardhan, K.D., Stanghellini, V., Armstrong, D., Berghofer, P., Gatz, G., Mönnikes, H. Evaluation of GERD symptoms during therapy. Part I. Development of the new GERD questionnaire ReQuest™. Digestion 2004, 69(4): 229-37.
8. Mönnikes, H., Bardhan, K.D., Stanghellini, V., Berghofer, P., Bethke, T.D., Armstrong, D. Evaluation of GERD symptoms during therapy. Part II. Psychometric evaluation and validation of the new questionnaire ReQuest™ in erosive GERD. Digestion 2004, 69(4): 238-44.
9. Bardhan, K.D., Stanghellini, V., Armstrong, D., Berghöfer, P., Gatz, G., Mönnikes, H. International validation of ReQuest™ in patients with endoscopy-negative gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2004, 20(8): 891-8.
10. Gatz, G., Braun, W. New insights into GERD symptomatology - The ReQuest™ database. Gut 2005, 54 (Suppl VII): A112.
11. Fass, R., Berghofer, P., Gatz, G., Hein, J., Mönnikes, H. Symptom pattern determines the time to first symptom relief in erosive esophagitis (EE) patients treated with a proton pump inhibitor (PPI). Gut 2005, 54 (Suppl VII): A109.
12. Glatzel, D., Abdel-Qader, M., Gatz, G., Pfaffenberger, B., Sander, P. Pantoprazole 40 mg is as effective as esomeprazole 40 mg to relieve symptoms of gastroesophageal reflux disease (GERD) after 4 weeks of treatment and superior regarding preventing of symptomatic relapse. Gut 2005, 54 (Suppl VII): A105.
13. Bardhan, K.D., Armstrong, D., Fass, R., Berghöfer, P., Gatz, G., Mönnikes H. The ReQuest™ / LA-classification: A novel integrated approach for the comprehensive assessment of the treatment outcome. Gut 2005, 54 (Suppl VII): A53.
14. Stanghellini, V., Armstrong, D., Mönnikes, H., Berghöfer, P., Gatz, G., Bardhan, K.D. Determination of ReQuest™-based symptom thresholds to define symptom relief in GERD clinical studies. Digestion 2005, 71: 145-51.
15. Stanghellini, V., Armstrong, D., Mönnikes, H. et al. Objective definition of symptom relief in clinical studies: Determination of international GERD symptom thresholds based on ReQuest™. Gastroenterology 2006 (in press).
16. Bardhan, K.D., Achim, A., Riddermann, T., Sander, P., Pfaffenberger, B. Achieving complete remission in patients with erosive gastroesophageal reflux disease (GERD): Pantoprazole is comparable with esomeprazole. Gut 2005, 54 (Suppl VII): A106.